Cerebrotendinous Xanthomatosis (CTX)

DBCOND0058089Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesNutritional and Metabolic Diseases

Cerebrotendinous Xanthomatosis (CTX) is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.

Also known as
Xanthomatosis, Cerebrotendinous · Cerebrotendinous Xanthomatosis · CTX - Cerebrotendinous Xanthomatosis
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0028726SNOMED CT63246000MedDRA10091530UMLSC0238052

What you can answer from here — as of October 23, 2026

1Indicated drugWith each drug's targets and mechanism
Listed above
1Structured indicationPopulation, line of therapy, route and combination as fields, not prose
Sign in
11Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Cerebrotendinous Xanthomatosis (CTX) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In